<DOC>
	<DOCNO>NCT00185419</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness term prevention pregnancy safety oral contraceptive Yasmin Marvelon cycle control healthy Chinese woman</brief_summary>
	<brief_title>A Clinical Study Yasmin® vs. Marvelon® Chinese Women Requiring Contraception</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer Schering Pharma AG , Germany . Bayer Schering Pharma AG , Germany sponsor trial .</detailed_description>
	<mesh_term>Drospirenone</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<mesh_term>Drospirenone ethinyl estradiol combination</mesh_term>
	<criteria>Healthy Chinese female request contraceptive Vascular , metabolic , hepatic , renal , oncologic disease</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>